AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · IEX Real-Time Price · USD
9.61
-0.17 (-1.74%)
Apr 25, 2024, 12:43 PM EDT - Market open

Company Description

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States.

The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies.

The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

AdaptHealth Corp.
AdaptHealth logo
Country United States
Industry Medical Devices
Sector Healthcare
Employees 10,700
CEO Richard Alan Barasch

Contact Details

Address:
220 West Germantown Pike, Suite 250
Plymouth Meeting, Pennsylvania 19462
United States
Phone 610-630-6357
Website adapthealth.com

Stock Details

Ticker Symbol AHCO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001725255
CUSIP Number 00653Q102
ISIN Number US00653Q1022
Employer ID 82-3677704
SIC Code 8082

Key Executives

Name Position
Richard Alan Barasch Chairman of the Board and Interim Chief Executive Officer
Joshua Parnes President and Director
Jason A. Clemens C.F.A. Chief Financial Officer
Albert A. Prast Chief Technology Officer
Christopher J. Joyce Secretary
Shaw A. Rietkerk Chief Operating Officer
Christie E. Archbold Chief Accounting Officer
Anton Hie Vice President of Investor Relations
Wendy Russalesi Chief Compliance Officer
Jonathan B. Bush General Counsel

Latest SEC Filings

Date Type Title
Apr 17, 2024 8-K Current Report
Apr 12, 2024 PRE 14A Other preliminary proxy statements
Mar 4, 2024 144 Filing
Mar 4, 2024 8-K Current Report
Feb 27, 2024 10-K Annual Report
Feb 27, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals